2 withdrawn. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Relapse: new trials by email Literature Review of Relapse trials Research Report on Relapse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia Primaquine double dose over 14 days, Primaquine single dose over 14 days - Malaria, Vivax, Relapse | Phase 2 / Phase 3 | Withdrawn | University of California, San Francisco | 2023-01-20 | 2023-05-11 | |
| "The Evaluation of Stimulant Withdrawal" Coreg - Anxiety, Relapse | Phase 2 | Withdrawn | Aaron J. Janowsky | 2007-07-01 | 2019-01-31 |
Recurrence (2) · Anxiety Disorders (1) · Malaria, Vivax (1) · Substance-Related Disorders (1)
Disease Attributes (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Chemically-Induced Disorders (1) · Infections (1) · Malaria (1) · Mental Disorders (1) · Mosquito-Borne Diseases (1) · Parasitic Diseases (1) · Protozoan Infections (1) · Vector Borne Diseases (1)
Carvedilol (1) · Primaquine (1)
Aaron J. Janowsky (1) · University of California, San Francisco (1)
United States (1)
P50DA018165 (1)